Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ABVXABVX
Showing 8 of 11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ABIVAX SA

Yes. Citadel Advisors holds 1,438,352 shares of ABVX (Abivax), worth $191.7M, as of its Q2 2026 13F filing. It increased the position by 894,014 shares (+164.2%) from Q1 2026. Citadel Advisors has held ABVX since Q4 2023, across 11 quarterly 13F filings.

Current Value

$191.7M

Current Shares

1.4M

Total Value Change

+$186.3M

Total Shares Change

+971,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+164.2%
$191.7M0.0%$133.26
49
2026-Q1
Decreased
544,338
-3.4%
$60.6M0.0%$111.10
0
2025-Q4
Decreased
563,747
-17.3%
$76M0.0%$138.34
0
2025-Q3
Decreased
681,785
-45.6%
$57.9M0.0%$83.33
0
2025-Q2
Decreased
1.3M
-8.8%
$9.6M0.0%$7.40
0
2025-Q1
Increased
1.4M
+60.6%
$8.6M0.0%$6.43
40
2024-Q4
Increased
855,676
+83.5%
$6.3M0.0%$7.05
42
2024-Q3
Increased
466,429
+2.6%
$5.4M0.0%$11.60
28

Other major holders of ABVX: UBS Group AG, MORGAN STANLEY, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used